Micro Patches
Edward
While traditional patches lay flat on the surface of the skin, these ultra thin micro-darts gently penetrate the skin, infusing serum for deeper delivery. Precise and powerful, they infuse serum where you need it most and fully absorb into the skin - for deeper, better, faster results!
Didn't expect it to work but they proved me wrong. It looks much more clear in person than the photos. My dark circles and puffiness are less visible. There's no pain at all they're comfortable while wearing to sleep."
For optimal results, we suggest applying the patches for a minimum of 2 hours, but preferably overnight. Leaving the patches on whilst you sleep ensures that the serum has ample time to dissolve and penetrate into the skin, maximizing its effectiveness to give you the best results.
Absolutely! Each of our patches undergoes rigorous dermatologist approval and testing. Our Micro-Infusion patches are crafted in a state-of-the-art facility laboratory in South Korea, adhering to the highest standards of safety.
For individuals with sensitive skin, we advise conducting a patch test before using our Micro-Infusion patches. Avoid applying them on open wounds, cuts, irritated, or infected skin. If you experience any irritation or rash then discontinue usage immediately.
Yes! Many pregnant women avoid injectables, retinols, or any strong acids for anti-aging during this time, so many turn to Qure as a safer alternative. However we always recommend speaking with a medical professional for advice prior to use.
Our products are not intended to diagnose, cure, or prevent specific diseases of medical conditions. The Qure website is for education and information purposes only and is not intended as medical advice or a substitute for medical advice.
This optional protection is offered to you solely in order to effectuate the shipment of your package(s). The cost of adding your shipment to the SecureShip Policy includes compensation paid to SecureShip for making this protection available.
These cookies are essential for the website to function properly. They enable basic functionalities like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
A National Institutes of Health-funded study led by a team at the Georgia Institute of Technology and Emory University has shown that an influenza vaccine can produce robust immune responses and be administered safely with an experimental patch of dissolving microneedles. The method is an alternative to needle-and-syringe immunization; with further development, it could eliminate the discomfort of an injection as well as the inconvenience and expense of visiting a flu clinic.
The study, published online June 27, 2017, in The Lancet, was led by Nadine Rouphael, M.D., associate professor of medicine and Mark J. Mulligan, M.D., distinguished professor of medicine, Emory University School of Medicine, in collaboration with Mark R. Prausnitz, Ph.D., Regents Professor and J. Erskine Love Chair in Chemical and Biomolecular Engineering, Georgia Institute of Technology. A team led by Prausnitz designed the dime-sized patch of microneedles used in the study.
Adhesive helps the patch grip the skin during the administration of the vaccine, which is encapsulated in the needles and is released as the needle tips dissolve, within minutes. The patch is peeled away and discarded like a used bandage strip.
The researchers enrolled 100 adult participants, dividing them into four random groups: vaccination with microneedle patch given by a health care provider; vaccination with microneedle patch self-administered by the study participant; vaccination with intramuscular injection given by a health care provider; and placebo microneedle patch given by a health care provider. The researchers used an inactivated influenza vaccine formulated for the 2014-15 flu season to inoculate participants other than those in the placebo group.
The researchers found that vaccination with the microneedle patches was safe, with no serious related adverse events reported. Some participants developed local skin reactions to the patches, described as faint redness and mild itching that lasted two to three days.
The results also showed that antibody responses generated by the vaccine, as measured through analysis of blood samples, were similar in the groups vaccinated using patches and those receiving intramuscular injection, and these immune responses were still present after six months. More than 70 percent of patch recipients reported they would prefer patch vaccination over injection or intranasal vaccination for future vaccinations.
No significant difference was seen between the doses of vaccine delivered by the health care workers and the volunteers who self-administered the patches, showing that participants were able to correctly self-administer the patch. After vaccination, imaging of the used patches found that the microneedles had dissolved in the skin, suggesting that the used patches could be safely discarded as non-sharps waste. The vaccines remained potent in the patches without refrigeration for at least one year.
The prospective vaccine technology could offer economic and manufacturing advantages. The manufacturing cost for the patch is expected to be competitive with prefilled syringe costs. The patch, however, can dramatically reduce the cost of vaccination, since self-administration can eliminate the need to have health workers oversee the process. It can be easily packaged for transportation, requires no refrigeration, and is stable.
Prausnitz is co-founder of a company that is licensing the microneedle patch technology. He is an inventor on licensed patents and has ownership interest in companies developing microneedle products, including Micron Biomedical. These potential conflicts of interest have been disclosed and are overseen by Georgia Institute of Technology and Emory University.
About the National Institutes of Health (NIH):NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.
Target trouble spots with these high-performance Line Minimizer Micro-Darts Pro - Fine Line Facial Patches that penetrate into the surface layers of skin. Moisturizing Hyaluronic Acid is paired with nourishing Peptides to help smooth the appearance of fine lines and improve skin elasticity for a more youthful glow. Non-invasive and ideal for all skin types.
After cleansing, completely dry the patch application area. Remove the protective film and apply the patch to desired area of the face. Lightly press the patch a few times to secure in place. Allow 2+ hours for the micro-darts to fully dissolve before removing. For best results, use weekly.
DESCRIPTION:
Experience micro-beauty-moments while you relax and luxuriate as you target smile lines caused by aging and dryness. Cross-linked Hyaluronic Acid hydrates and replenishes moisture while Hydrolyzed Collagen helps plump and firm fine lines and wrinkles without the need for injections.
MICRO-TIPS:
Contains Approximately 2,000 Micro-Tips (1,000 micro-tips per patch) infused with a high concentration of Hyaluronic Acid which boost moisture while filling in fine lines and wrinkles caused by aging and dryness.
1. Open the pouch and carefully remove the film containing the patch from tray. Do not touch the center of the patch.
2. Hold the film on one hand and completely remove the white protective film from the patch.
3. Gently place the adhesive side down, directly onto your under eye skin.
4. Press the patch straight down to firmly adhere to skin. For best results, wear overnight or for at least four hours. Remove and discard patches. Follow with your usual skincare routine.
These self-dissolving micro tips are like little magic wands, melting deep into the skin to target and fill fine lines with precision. What's even better? You can wear them overnight and wake up refreshed and hydrated!
To say that I'm OBSESSED with these 3D Microfiller Patches is an understatement! I've been using them consistently for 3 months now and let me just say...my fine lines and baby wrinkles have diminished significantly. If you're looking to defy visible signs of aging these patches are your girl. The best part? They completely self-dissolve while you sleep. Don't walk...run!!
2600 dissolving microneedles melt under the surface of the skin for improved delivery of active ingredients. Designed for the under eye area and for fine lines and wrinkles anywhere on your face (think crow's feet, smile lines, forehead wrinkles).
New and improved: With caffeine having emerging evidence in anti-aging (improving the skin barrier and boosting microcirculation), we added it to Ageless along with 30% more microneedles to reduce under eye bags and puffiness!
Microneedle eye patch - 4 pack contains 16 patches.
Each patch contains 2,000 dissolving hyaluronic acid microneedles embedded with Retinal, Niacinamide, Hyaluronic Acid, Copper Peptide, Ferulic Acid, Resveratrol and more. Each dissolving needle is 0.3 millimeters in length, painlessly reaching the deeper layers of the skin.
While Ageless patches will have a small effect after just one use (due to the application of hyaluronic acid). Studies showing the real effectiveness of dissolving microneedle patches allow for 8 to 12 weeks
Technological advances have allowed acne busting actives to be incorporated into dissolving microneedles. These tiny needles can painlessly penetrate the skin barrier where they create a micro-wound. This sounds terrible but when the skin starts to heal it stimulates a cascade of chemical reactions that include growth factors to stimulate new skin cells along with new collagen and elastin to rejuvenate the face.
c80f0f1006